Patents by Inventor Chin-Sheng HUNG

Chin-Sheng HUNG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for early prediction, treatment response, recurrence and prognosis monitoring of breast cancer
    Patent number: 12203140
    Abstract: The present invention discloses a set of novel epigenetic biomarkers for early prediction, treatment response, recurrence and prognosis monitoring of a breast cancer. Aberrant methylation of the genes can be detected in tumor tissues and plasma samples from breast cancer patients but not in normal healthy individual. The present disclosure also discloses primers and probes used herein.
    Type: Grant
    Filed: May 8, 2019
    Date of Patent: January 21, 2025
    Assignee: EG BIOMED CO., LTD.
    Inventors: Ruo-Kai Lin, Chin-Sheng Hung, Sheng-Chao Wang, Yu-Mei Chung, Chih-Ming Su
  • METHOD FOR EARLY DETECTION, PREDICTION OF TREATMENT RESPONSE AND PROGNOSIS OF COLORECTAL CANCER
    Publication number: 20240247316
    Abstract: The present disclosure discloses a set of novel epigenetic biomarkers for early detection, prediction of treatment response and prognosis of colorectal cancer. Aberrant methylation of the epigenetic biomarkers can be detected in tumor tissues and plasma samples from colorectal cancer patients but not in normal individuals. The present disclosure also discloses primers and probes used herein.
    Type: Application
    Filed: April 29, 2021
    Publication date: July 25, 2024
    Inventors: Ruo-Kai LIN, Chin-Sheng HUNG, Sheng-Chao WANG, Shih-Yun LIN
  • METHODS FOR EARLY PREDICTION, TREATMENT RESPONSE, RECURRENCE AND PROGNOSIS MONITORING OF BREAST CANCER
    Publication number: 20210189500
    Abstract: The present invention discloses a set of novel epigenetic biomarkers for early prediction, treatment response, recurrence and prognosis monitoring of a breast cancer. Aberrant methylation of the genes can be detected in tumor tissues and plasma samples from breast cancer patients but not in normal healthy individual. The present disclosure also discloses primers and probes used herein.
    Type: Application
    Filed: May 8, 2019
    Publication date: June 24, 2021
    Inventors: Ruo-Kai LIN, Chin-Sheng HUNG, Sheng-Chao WANG, Yu-Mei CHUNG, Chih-Ming SU